Latest articles
To the Editor, The importance of blood pressure control in improving kidney outcomes in patients with immunoglobulin A nephropathy (IgAN) has long been recognized. However, no study has evaluated the prognostic value of ambulatory blood pressure (ABP) monitoring, the most reliable method of blood ...
The ERA Registry would like to thank the patients and staff of all the dialysis and transplant units who have contributed data via their national and regional renal registries. A.O. is one of the former Editors-in-Chief of CKJ and has received support for medical writing from Astellas and Open ...
Most cited
In the EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) trial, empagliflozin reduced cardiorenal outcomes by 28% (hazard ratio 0.72; 95% confidence interval 0.64–0.82; P < .0001) in a diverse population of over 6000 chronic kidney disease (CKD) patients, of whom >50% were not diabetic. It ...
Background The European Renal Association (ERA) Registry collects data on kidney replacement therapy (KRT) in patients with end-stage kidney disease (ESKD). This paper is a summary of the ERA Registry Annual Report 2021, including a comparison across treatment modalities. Methods Data was collected from 54 national and ...
The prevalence of obesity has tripled over the past five decades. Obesity, especially visceral obesity, is closely related to hypertension, increasing the risk of primary (essential) hypertension by 65%–75%. Hypertension is a major risk factor for cardiovascular disease, the leading cause of death worldwide, and its ...
Introduction Chronic kidney disease (CKD) is a significant public health problem, with rising incidence and prevalence worldwide, and is associated with increased morbidity and mortality. Early identification and treatment of CKD can slow its progression and prevent complications, but it is not clear whether CKD screening ...
There is growing evidence that chronic kidney disease (CKD) is an independent risk factor for cognitive impairment, especially due to vascular damage, blood–brain barrier disruption and uremic toxins. Given the presence of multiple comorbidities, the medication regimen of CKD patients often becomes very complex. Several ...
Advances in our understanding of the pathogenesis of immunoglobulin A nephropathy (IgAN) have led to the identification of novel therapeutic targets and potential disease-specific treatments. Specifically, a proliferation-inducing ligand (APRIL) has been implicated in the pathogenesis of IgAN, mediating B-cell ...
Impact Factor
3.9
Impact Factor Rank
Urology & Nephrology 18 out of 126
5-year IF
3.8
CiteScore
6.7
CiteScore Rank
Nephrology 12 out of 81
Transplantation 13 out of 54
ERA Journal Club e-seminars
The ERA Journal Club e-seminars aim to initiate an open discussion among the nephrology community on how the results obtained in the recent trials can be applied to the needs of patients.
February 27, 2025
From 5:00 to 5:45 PM (CET)
Author Videos
Video is a dynamic feature of the journal, providing a multimedia experience for readers. With our tools and guidelines, authors present their article in brief, easy to watch videos that cover recent reviews, reports, original research, and more.
Cardio-Kidney Collection
This collection of scientific articles, curated as a joint effort by the European Renal Association (ERA) and the European Society of Cardiology (ESC), sheds light on the critical importance of addressing the intertwined nature of cardiovascular, kidney, and metabolic disorders.
Explore today
Reasons to Publish in CKJ
CKJ is a leading journal in the field of nephrology. When you publish with CKJ, your article benefits from a wide array of journal features, including global readership, community engagement, and multimedia opportunities.
Explore journal benefits
Read and Publish
Authors interested in publishing in CKJ may be able to publish their paper Open Access using funds available through their institution’s agreement with OUP.
Find out if your institution is participating
More from the ERA
Learn about the ERA journals, including the benefits of becoming a member, the ERA Congress, the ERA Journal Club, the ERA App, and more.
Find out more
